The 10-second takeaway
For the quarter ended Dec. 31 (Q1), DR Horton beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew significantly and GAAP earnings per share expanded significantly.
Margins expanded across the board.
DR Horton reported revenue of $1.28 billion. The 10 analysts polled by S&P Capital IQ predicted revenue of $1.13 billion on the same basis. GAAP reported sales were 41% higher than the prior-year quarter's $906.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.20. The 18 earnings estimates compiled by S&P Capital IQ averaged $0.14 per share. GAAP EPS of $0.20 for Q1 were 122% higher than the prior-year quarter's $0.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 19.5%, 250 basis points better than the prior-year quarter. Operating margin was 8.5%, 460 basis points better than the prior-year quarter. Net margin was 5.2%, 210 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.21 billion. On the bottom line, the average EPS estimate is $0.16.
Next year's average estimate for revenue is $5.68 billion. The average EPS estimate is $0.89.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 577 members out of 1,136 rating the stock outperform, and 559 members rating it underperform. Among 322 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 169 give DR Horton a green thumbs-up, and 153 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on DR Horton is outperform, with an average price target of $21.23.
Looking for alternatives to DR Horton? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.
- Add DR Horton to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.